期刊文献+

Advanced gastric cancer:what we know and what we stillhave to learn 被引量:26

Advanced gastric cancer: what we know and what we still have to learn
下载PDF
导出
摘要 Gastric cancer is a common neoplastic disease and, more precisely, is the third leading cause of cancer death in the world, with differences amongst geographic areas. The definition of advanced gastric cancer is still debated. Different stadiating systems lead to slightly different stadiation of the disease, thus leading to variations between the single countries in the treatment and outcomes. In the present review all the possibilities of treatment for advanced gastric cancer have been analyzed. Surgery, the cornerstone of treatment for advanced gastric cancer, is analyzed first, followed by an investigation of the different forms and drugs of chemotherapy and radiotherapy. New frontiers in treatment suggest the growing consideration for intraperitoneal administration of chemotherapeutics and combination of traditional drugs with new ones. Moreover, the necessity to prevent the relapse of the disease leads to the consideration of administering intraperitoneal chemotherapy earlier in the therapeutical algorithm. Gastric cancer is a common neoplastic disease and, more precisely, is the third leading cause of cancer death in the world, with differences amongst geographic areas. The definition of advanced gastric cancer is still debated. Different stadiating systems lead to slightly different stadiation of the disease, thus leading to variations between the single countries in the treatment and outcomes. In the present review all the possibilities of treatment for advanced gastric cancer have been analyzed. Surgery, the cornerstone of treatment for advanced gastric cancer, is analyzed first, followed by an investigation of the different forms and drugs of chemotherapy and radiotherapy. New frontiers in treatment suggest the growing consideration for intraperitoneal administration of chemotherapeutics and combination of traditional drugs with new ones. Moreover, the necessity to prevent the relapse of the disease leads to the consideration of administering intraperitoneal chemotherapy earlier in the therapeutical algorithm.
出处 《World Journal of Gastroenterology》 SCIE CAS 2016年第3期1139-1159,共21页 世界胃肠病学杂志(英文版)
关键词 Advanced gastric cancer CHEMOTHERAPY hypertermic INTRAPERITONEAL CHEMOTHERAPY IntraTOPIC PERITONEAL Surgery Definition Advanced gastric cancer Chemotherapy Hypertermic intraperitoneal chemotherapy Intraperitoneal Surgery Definition
  • 相关文献

参考文献2

二级参考文献81

  • 1Stefano Rausei,Gianlorenzo Dionigi,Francesca Rovera,Luigi Boni,Caterina Valerii,Luisa Giavarini,Francesco Frattini,Renzo Dionigi.A decade in gastric cancer curative surgery:Evidence of progress(1999-2009)[J].World Journal of Gastrointestinal Surgery,2012,4(3):45-54. 被引量:1
  • 2Shimada Y. JGCA (The Japan Gastric Cancer Association).Gastric cancer treatment guidelines. Jpn J Clin Oncol 2004;34: 58 [PMID: 15061149].
  • 3Piazuelo MB, Correa P. Gastric cáncer: Overview. ColombMed (Cali) 2013; 44: 192-201 [PMID: 24892619].
  • 4Tanaka H. Advances in cancer epidemiology in Japan. IntJ Cancer 2014; 134: 747-754 [PMID: 24105756 DOI: 10.1002/ijc.28519].
  • 5Songun I, Putter H, Kranenbarg EM, Sasako M, van deVelde CJ. Surgical treatment of gastric cancer: 15-yearfollow-up results of the randomised nationwide DutchD1D2 trial. Lancet Oncol 2010; 11: 439-449 [PMID: 20409751DOI: 10.1016/S1470-2045(10)70070-X].
  • 6Morton DL, Wen DR, Wong JH, Economou JS, CagleLA, Storm FK, Foshag LJ, Cochran AJ. Technical detailsof intraoperative lymphatic mapping for early stagemelanoma. Arch Surg 1992; 127: 392-399 [PMID: 1558490DOI: 10.1001/archsurg.1992.01420040034005].
  • 7Giuliano AE, Kirgan DM, Guenther JM, Morton DL.Lymphatic mapping and sentinel lymphadenectomy forbreast cancer. Ann Surg 1994; 220: 391-398; discussion391-398 [PMID: 8092905 DOI: 10.1097/00000658-199409000-00015].
  • 8Bilchik AJ, Saha S, Wiese D, Stonecypher JA, Wood TF,Sostrin S, Turner RR, Wang HJ, Morton DL, Hoon DS.Molecular staging of early colon cancer on the basis ofsentinel node analysis: a multicenter phase II trial. J ClinOncol 2001; 19: 1128-1136 [PMID: 11181678].
  • 9Becher RD, Shen P, Stewart JH, Geisinger KR, McCarthyLP, Levine EA. Sentinel lymph node mapping for gastricadenocarcinoma. Am Surg 2009; 75: 710-714 [PMID: 19725295].
  • 10Lips DJ, Schutte HW, van der Linden RL, Dassen AE,Voogd AC, Bosscha K. Sentinel lymph node biopsy todirect treatment in gastric cancer. A systematic review ofthe literature. Eur J Surg Oncol 2011; 37: 655-661 [PMID:21636243 DOI: 10.1016/j.ejso.2011.05.001].

共引文献19

同被引文献142

引证文献26

二级引证文献172

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部